节点文献

诺卡氏菌原生质体融合重组研究

STUDIES ON RECOMBINATION OF NOCARDIA SP.THROUGH PROTOPLAST FUSION

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 贺敏霞; 史济平; 褚志义;

【Author】 He Minxia Shi Jiping Chu Zhiyi (Department of Biosynthetic Pharmaceutics, School of Pharmacy, Shanghai Medical University, Shanghai)

【机构】 上海医科大学药学院生物合成药化教研究室;

【摘要】 本文报道Nocardia sp.48(Str~r Rif~s)和Nocardia sp.189(Str~sRif~r)原生质体融合结果。42%PEG6000获最高融合频率。经一定时间的表型延迟后检出抗性互补的融合子。用电子显微镜观察了原生质体融合过程。融合子形态多样,耐双药性状稳定。有四株融合子产生亲本没有的甾体转化中间体,三株融合子产生亲本没有的抗生物质,还得到一株甾体转化活力明显高于亲本的融合子。

【Abstract】 This paper reports the result of recombination by protoplast fusion between Nocardia sp.48 (Strr Rifs) and Nocardia sp.189 (Strs Rifr). The maximum recombinant frequency reached 4.39×10-3 by treatment of 42% polyethylene glycol 6000. Fusants could grow only if Streptomycin and Rifampin were added to the regeneration medium after waiting the phenotypie lag. The processes of protoplast fusion was observed with electrort microscope.Besides a variety of colony shape, Four fusants produced a new intermediate compound of steroid transformation. Three fusants generated antibiotic substances, which their parents didn’t produced. We also obtain a fusant whose steroid converting rate was obviously higher than its parants.

【关键词】 原生质体融合; 重组; 诺卡氏菌;
【Key words】 Protoplast fusion; rccombination; Nocardia;
  • 【文献出处】 生物工程学报 ,Chinese Journal of Biotechnology , 编辑部邮箱 ,1989年04期
  • 【被引频次】30
  • 【下载频次】53
节点文献中: 

本文链接的文献网络图示:

本文的引文网络